Technical Analysis for CRSP - CRISPR Therapeutics AG
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 71.47 | -2.03% | -1.48 |
CRSP closed down 2.03 percent on Monday, March 18, 2024, on 59 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
MACD Bearish Centerline Cross | Bearish | 0.00% | |
Lower Bollinger Band Walk | Weakness | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
50 DMA Support | Bullish | -2.03% | |
Pocket Pivot | Bullish Swing Setup | -2.03% | |
NR7 | Range Contraction | -2.03% | |
Inside Day | Range Contraction | -2.03% | |
Lower Bollinger Band Touch | Weakness | -2.03% |
Alert | Time |
---|---|
Fell Below 50 DMA | about 22 hours ago |
50 DMA Support | about 22 hours ago |
Outside Day | about 22 hours ago |
Fell Below Previous Day's Low | about 22 hours ago |
Down 2 % | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 02/19/2024
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Genetic Engineering Enzymes Precision Medicine DNA CRISPR Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Genetic Engineering Enzymes Precision Medicine DNA CRISPR Genome Editing Cas9
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 91.1 |
52 Week Low | 37.55 |
Average Volume | 2,057,811 |
200-Day Moving Average | 58.82 |
50-Day Moving Average | 72.10 |
20-Day Moving Average | 80.37 |
10-Day Moving Average | 76.34 |
Average True Range | 3.90 |
RSI (14) | 39.76 |
ADX | 26.84 |
+DI | 20.99 |
-DI | 22.46 |
Chandelier Exit (Long, 3 ATRs) | 79.42 |
Chandelier Exit (Short, 3 ATRs) | 82.81 |
Upper Bollinger Bands | 90.58 |
Lower Bollinger Band | 70.15 |
Percent B (%b) | 0.06 |
BandWidth | 25.42 |
MACD Line | -0.23 |
MACD Signal Line | 1.65 |
MACD Histogram | -1.875 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 75.20 | ||||
Resistance 3 (R3) | 75.54 | 74.64 | 74.58 | ||
Resistance 2 (R2) | 74.64 | 73.68 | 74.47 | 74.37 | |
Resistance 1 (R1) | 73.05 | 73.10 | 72.60 | 72.71 | 74.17 |
Pivot Point | 72.15 | 72.15 | 71.92 | 71.98 | 72.15 |
Support 1 (S1) | 70.56 | 71.20 | 70.11 | 70.23 | 68.77 |
Support 2 (S2) | 69.66 | 70.61 | 69.49 | 68.57 | |
Support 3 (S3) | 68.08 | 69.66 | 68.36 | ||
Support 4 (S4) | 67.74 |